Literature DB >> 28980052

Right Ventricular Tissue Doppler Myocardial Performance Index in Children with Pulmonary Hypertension: Relation to Invasive Hemodynamics.

Richard M Friesen1, Michal Schäfer2,3, Dale A Burkett2, Courtney J Cassidy2, D Dunbar Ivy2, Pei-Ni Jone2.   

Abstract

Right ventricular (RV) failure is a significant cause of morbidity and mortality in patients with pulmonary hypertension (PH). Myocardial performance index measured by tissue Doppler imaging (TDI-MPI) has been useful in assessing RV dysfunction in adults with PH. However, TDI-MPI as a marker for RV dysfunction or disease severity has not been evaluated in pediatric PH. The aim of this study was to investigate TDI-MPI and correlate with invasive hemodynamics in pediatric PH patients. Eighty pediatric PH patients undergoing cardiac catheterization and simultaneous transthoracic echocardiography were analyzed. RV TDI-MPI was averaged over three cardiac cycles and measured under each condition of vasodilatory testing during the catheterization. TDI-MPI was compared between PH patients and age-matched controls and correlated to invasive hemodynamics. RV TDI-MPI was increased in PH patients compared to controls (0.49 vs. 0.35, p < 0.0001). Significant associations (beta ± SE) are seen between RV TDI-MPI and baseline mean pulmonary arterial pressures (0.0002 ± 0.001, p < 0.05), indexed pulmonary vascular resistance (0.007 ± 0.002, p < 0.002), and pulmonary-to-systemic arterial pressure ratio (0.146 ± 0.063, p < 0.05). No statistically significant associations were seen with vasodilatory testing. RV TDI-MPI is elevated in children with PH, suggestive of RV dysfunction. RV TDI-MPI shows correlation with severity of PH at baseline but lacks sensitivity to evaluate the RV response to acute changes in afterload in children with PH. Therefore, while RV TDI-MPI can help identify RV dysfunction in children with PH, its utility as a non-invasive surrogate marker for acute changes in hemodynamics is limited.

Entities:  

Keywords:  Echocardiography; Pediatrics; Pulmonary hypertension

Mesh:

Substances:

Year:  2017        PMID: 28980052     DOI: 10.1007/s00246-017-1733-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  30 in total

1.  The relation between quantitative right ventricular ejection fraction and indices of tricuspid annular motion and myocardial performance.

Authors:  Darryl Miller; Michel G Farah; Anna Liner; Keith Fox; Mark Schluchter; Brian D Hoit
Journal:  J Am Soc Echocardiogr       Date:  2004-05       Impact factor: 5.251

2.  Comparison of the Tei index with invasive measurements of right ventricular function.

Authors:  Juan C Grignola; Fernando Ginés; Daniel Guzzo
Journal:  Int J Cardiol       Date:  2005-12-02       Impact factor: 4.164

3.  Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.

Authors:  Yoshito Ogihara; Norikazu Yamada; Kaoru Dohi; Akimasa Matsuda; Akihiro Tsuji; Satoshi Ota; Ken Ishikura; Mashio Nakamura; Masaaki Ito
Journal:  J Cardiol       Date:  2013-09-04       Impact factor: 3.159

4.  Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study.

Authors:  Javier Sanz; Ana García-Alvarez; Leticia Fernández-Friera; Ajith Nair; Jesús G Mirelis; Simonette T Sawit; Sean Pinney; Valentin Fuster
Journal:  Heart       Date:  2011-09-13       Impact factor: 5.994

5.  Doppler echocardiographic index for assessment of global right ventricular function.

Authors:  C Tei; K S Dujardin; D O Hodge; K R Bailey; M D McGoon; A J Tajik; S B Seward
Journal:  J Am Soc Echocardiogr       Date:  1996 Nov-Dec       Impact factor: 5.251

6.  Prognostic significance of 2-dimensional, M-mode, and Doppler echo indices of right ventricular function in children with pulmonary arterial hypertension.

Authors:  Eias Kassem; Tilman Humpl; Mark K Friedberg
Journal:  Am Heart J       Date:  2013-04-06       Impact factor: 4.749

7.  New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy.

Authors:  C Tei; L H Ling; D O Hodge; K R Bailey; J K Oh; R J Rodeheffer; A J Tajik; J B Seward
Journal:  J Cardiol       Date:  1995-12       Impact factor: 3.159

8.  Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.

Authors:  Steven H Abman; Georg Hansmann; Stephen L Archer; D Dunbar Ivy; Ian Adatia; Wendy K Chung; Brian D Hanna; Erika B Rosenzweig; J Usha Raj; David Cornfield; Kurt R Stenmark; Robin Steinhorn; Bernard Thébaud; Jeffrey R Fineman; Titus Kuehne; Jeffrey A Feinstein; Mark K Friedberg; Michael Earing; Robyn J Barst; Roberta L Keller; John P Kinsella; Mary Mullen; Robin Deterding; Thomas Kulik; George Mallory; Tilman Humpl; David L Wessel
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

9.  Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; D Dunbar Ivy; Steven H Abman
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

10.  Non-invasive determination by cardiovascular magnetic resonance of right ventricular-vascular coupling in children and adolescents with pulmonary hypertension.

Authors:  Uyen Truong; Sonali Patel; Vitaly Kheyfets; Jamie Dunning; Brian Fonseca; Alex J Barker; Dunbar Ivy; Robin Shandas; Kendall Hunter
Journal:  J Cardiovasc Magn Reson       Date:  2015-09-16       Impact factor: 5.364

View more
  2 in total

Review 1.  Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children.

Authors:  Benjamin S Frank; D Dunbar Ivy
Journal:  Children (Basel)       Date:  2018-03-23

2.  EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Authors:  David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift
Journal:  Pulm Circ       Date:  2019-03-18       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.